Retired Compendial Notices: 2010-2014
- <1> Injections, Labeling of Ferrules and Cap Overseals Section (posted 04–Aug–2010)
- <1> Injections and <788> Particulate Matter in Injections (posted 26–Aug–2011)
- <1> Injections, Labeling of Ferrules and Cap Overseals Section (posted 4–Aug–2010)
- <3> USP Has Revised New General Chapter <3> Topical and Transdermal Drug Products: Quality Tests; To Be Republished in PF 36(6) (posted 20–Sep–2010)
- <7> Labeling (posted 29–Dec–2011)
- <17> USP Seeks Comments on Proposed General Chapter <17> Prescription Container Labeling (posted 03–Jan–2011)
- <17> Recommendations on Prescription Container Labeling (posted 26–Apr–2010)
- <41> Balances (posted 25–Oct–2013)
- <81> Antibiotics—Microbial Assays: USP Proposes Revisions in PF 365 (posted 27–Aug–2010)
- <232> Elemental Impurities—Limits (posted 27–Apr–2012; updated 21–Nov–2012)
- <233> Elemental Impurities—Procedures (posted 27–Apr–2012; updated 21–Nov–2012)
- <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures Revision Bulletin (posted 28–Jan–2013)
- <561> Articles of Botanical Origin (posted 27–Jun–2014)
- <659> Packaging and Storage Requirements (posted 27–Apr–2012; updated 21–Nov–2012)
- <797> Pharmaceutical Compounding—Sterile Preparations (posted 27–Dec–2013)
- <823> Radiopharmaceuticals for Positron Emission Tomography–Compound: Notice of Intent to Revise (posted 24–Nov–2010)
- <1066> Physical Environments that Promote Safe Medication Use: Notice of Intent to Revise (posted 30–Apr–2010)
- <1083> Good Distribution Practices—Supply Chain Integrity Posted for Comment, Workshop Scheduled (posted 29–Dec–2011)
- <1092> The Dissolution Procedure: Development and Validation, Proposed Revisions and Stimuli Article (posted 22–Nov–2013)
- <1121> Stimuli Article and Proposed Revisions (posted 29–Dec–2011)
- <1121> Nomenclature: Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations (posted 04–Jun–2007; official 01–May–2013)
- <1160> Pharmaceutical Calculations in Prescription Compounding (posted 25–Apr–2014)
- <1660> Evaluation of the Inner Surface Durability of Glass Containers Posted for Comment (posted 27–Apr–2012)
- <2232> Elemental Contaminants in Dietary Supplements (posted 27–Apr–2012)
- Implementation Deferred for General Chapters <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures (posted 24–May–2013)
- Acetaminophen (posted 26–Jul–2013)
- Admission Criteria and Safety Classification for Dietary Supplements Guideline Update (posted 18–Oct–2012)
- Additional Feedback Sought on Proposed Storage and Distribution General Chapters (posted 13–Jun–2014)
- Aluminum Sulfate and Calcium Acetate for Topical Solution (posted 31–Oct–2014)
- Amoxicillin and Clavulanate Potassium for Oral Suspension: Notice of Intent to Revise (posted 23–Nov–2011)
- Amoxicillin (posted 19–Dec–2014)
- Ampicillin (posted 01–Nov–2011)
- Atorvastatin Calcium (posted 25–Feb–2011)
- Benzalkonium Chloride and Benzalkonium Chloride Solution (posted 29–Dec–2011)
- Calcitonin Salmon Injection and Calcitonin Salmon Nasal Spray (posted 01–Oct–2013)
- Calcitonin Salmon Monographs (posted 28–Oct–2011)
- Carbidopa (posted 29–Dec–2011)
- Cefazolin Injection (posted 25–Apr–2014)
- Cefdinir for Oral Suspension (posted 27–Dec–2013)
- Cefdinir Capsules (posted 27–Dec–2013)
- Ceftriaxone Injection (posted 25–Apr–2014)
- Cephalexin Monographs (posted 07–Dec–2009; revised 30–Jun–2010)
- Change to General Chapters Reference to Preservation, Packaging, Storage and Labeling Section of General Notices (posted 18–May–2012)
- Chlorhexidine Acetate (11–Mar–2014)
- Chlorhexidine Gluconate Solution (11–Mar–2014)
- Chlorhexidine Hydrochloride (11–Mar–2014)
- Colloidal Oatmeal (posted 27–Apr–2012)
- Complete Reagent Section No Longer Being Printed in Supplements to USP–NF (posted 01–Feb–2013)
- Compounded Preparations Title Change (posted 29–Aug–2014)
- Container Content Reference Corrections in Monographs and General Chapter (posted 27–Jan–2012)
- Copovidone (posted 09–Aug–2011)
- Correction to Pharmacopeial Forum 39(1): General Chapter <601> Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers (posted 18–Jul–2013)
- Correction to Pharmacopeial Forum 39(1): Benzethonium Chloride (posted 20–Mar–2013)
- Correction to PF 39(4): Gabapentin (posted 31–Jul–2013)
- Errata Posting Schedule Revised (posted 14–Sep–2012)
- Errata Tables Corrected (posted 22–Feb–2013)
- Esmolol Hydrochloride (posted 28–Dec–2012)
- Ethylcellulose (posted 01–Mar–2011)
- First Prescription/Nonprescription Stakeholder Forum for 2010–2015 Cycle Enables Broader Participation (posted 08–October–2010)
- First Excipients Stakeholder Forum Scheduled for June (posted 22–Mar–2013)
- First Supplement to USP 37–NF 32 Online and USB Flash Drive Correction
- Ganoderma Lucidum Fruiting Body (27–Jun–2014)
- Ganoderma Lucidum Fruiting Body Powder (27–Jun–2014)
- General Chapter <911> Viscosity Reference Corrections in Monographs (posted 31–May–2012)
- General Notices 6.50.20 Solutions Erratum (posted 25–Jul–2014)
- General Notices (posted 27–Apr–2012)
- General Notices and Requirements: Proposed Revisions to be Published for Comment in PF (posted 05–Dec–2014)
- Proposed Revisions to the General Notices and Requirements Published for Comment in Pharmacopeial Forum 39(1) [Jan.–Feb. 2013] (posted 28–Dec–2012; updated 04–Feb–2013)
- Glacial Acetic Acid (posted 26–Mar–2010)
- Glycopyrrolate (posted 24–Feb–2012)
- Heparin Sodium Monograph Comment Period Extended (posted 30–Nov–2012)
- Heparin Lock Flush Solution (posted 29–Jun–2012)
- Heparin Sodium Injection: Notice of Intent to Revise (posted 24–Feb–2012)
- High Fructose Corn Syrup: Notice of Intent to Revise (posted 26–Oct–2012)
- Introduction to a General Chapter for Veterinary Products Posted For Comment, Workshop Scheduled (posted 22–May–2012)
- Levelbuterol Hydrochloride (posted 29–Jul–2011)
- Levelbuterol Inhalation Solution (posted 29–Jul–2011)
- Levalbuterol Inhalation Solution (posted 07–Feb–2014; updated 25–Apr–2014)
- List of Revised Titles in the Description and Solubility Reference Table of USP 36–NF31 2S (posted 03–Jun–2013)
- Loperamide Hydrochloride Oral Solution (posted 01–Oct–2013)
- Loratadine Oral Solution: Notice of Intent to Revise (posted 29–Oct–2010)
- Methylpyrrolidone: Notice of Intent to Revise (posted 01–Aug–2012)
- Mirtazapine Tablets (posted 29–Jul–2011)
- Monographs and GC Affected by Revisions to GC <231> Heavy Metals (25–Jul–2014; updated 31–Jul–2014)
- Nominations Being Accepted for the USP 2013 Awards Program (posted 26–Apr–2013)
- Norethindrone Acetate and Ethinyl Estradiol Tablets: Notice of Intent to Revise (posted 30–Jul–2010)
- Olanzapine Tablets (posted 27–May–2011)
- Omega-3-Acid Ethyl Esters (posted 30–May–2014; updated 27–Feb–2015)
- Online Enhancements to Help Users Access USP–NF New Official Text (posted 26–Oct–2012)
- Orlistat (posted 22–Mar–2013)
- Oxycodone Hydrochloride: Notice of Intent to Revise (POSTPONEMENT) (posted 24–Sep–2010)
- Pharmacopeial Forum Transitions to a Free, Online Resource in January 2011 (posted 8–Sep–2010)
- PF 37(6) Posting (posted 18–Nov–2011)
- Polymyxin B Sulfate (posted 28–Feb–2014)
- Polysorbate 20 (posted 27–Dec–2013)
- Prescription/Nonprescription Stakeholder Forum Date Announced (posted 06–Apr–2011)
- Prescription/Nonprescription Stakeholder Forum Scheduled (posted 24–Feb–2012)
- Prescription/Nonprescription Stakeholder Forum Scheduled for June; Agenda Topics Sought (posted 31–Jan–2013; deadline 30–Apr–2013)
- Propofol Injectable Emulsion: Notice of Intent to Revise (posted 28–Jan–2011)
- Protamine Sulfate Monographs (posted 26–Feb–2010)
- Publication Announcements for USP 37–NF 32 1S: General Chapter Format and Reagent PDFs (posted 31–Jan–2014)
- Reagent PDFs and Errata PDFs Online for USP 36–NF 31 2S (posted 31–May–2013)
- Revision Bulletins to be Posted Bimonthly (posted 31–Aug–2012)
- Revision to USP Pending Monographs Guideline (posted 30–Apr–2010)
- Revision to USP Pending Monographs Guideline (posted 30–Jul–2010)
- Revision to USP Pending Monographs Guideline (posted 23–Nov–2011)
- Searchable Errata Database Launches (posted 30–Nov–2012)
- Sesame Oil (posted 31–Oct–2014)
- Sertraline Tablets (posted 26–Aug–2011)
- Simethicone Emulsion: Notice of Intent to Revise (posted 27–Apr–2012)
- Stimuli Article on Lifecycle Management of Analytical Procedures Posted for Comment (posted 26–Jul–2013)
- Tacrolimus (posted 27–Jun–2014)
- Tacrolimus Capsules (posted 25–Oct–2013)
- Tamsulosin Hydrochloride Capsules: Notice of Intent to Revise (posted 30–Apr–2010)
- Tazobactam: Notice of Intent to Revise (posted 28–Jan–2011)
- Tramadol Hydrochloride: Notice of Intent to Revise (posted 29–Jun–2012)
- Travoprost Ophthalmic Solution (posted 25–Feb–2011)
- Updates to Chemical Information Section of USP–NF Monographs (posted 27–Dec–2013)
- USP 34–NF 29 December Errata Posting (posted 30–Dec–2010)
- USP 36–NF 31 Flash Drive Information (posted 11–Mar–2013)
- USP to Host Veterinary Medicines Events in November 2012, in Rockville, MD (posted 22–May–2012)
- USP Monograph Modernization Initiative (posted 08–Feb–2011)
- USP Public Statement on Completion of Evaluations of Recall of USP 33–NF 28 (posted 04–Oct–2010)
- USP Seeking Public Participation in Organic Impurities Survey (posted 26–Apr–2013)
- USP Seeking Public Participation in Residual Solvent Testing Survey (posted 26–Apr–2013)
- USP Seeks Submission of Proposals for Monograph Modernization (posted 28–May–2010)
- Vasopressin: Notice of Intent to Revise (posted 31–Mar–2011)
- Valacyclovir Hydrochloride (posted 30–Jun–2011)
- Vincristine Sulfate Monographs–USP Seeks Advice on Official Date: Notice of Intent to Revise (posted 30–Apr–2010)